HUTCHINSON-GILFORD PROGERIA SYNDROME: A PREMATURELY AGING DISORDER

Abstract

Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare genetic disorder characterized by premature aging, involving aberrant splicing of the LMNA gene, resulting in the production of a disease-causing mutant lamin A protein called progerin. Clinical manifestations are evident by the first or second year of life and include the physical characteristics usually associated with the elderly. Because neither parent carries or expresses the mutation, each case is believed to represent a sporadic, new mutation that happens most notably in a single sperm or egg immediately prior to conception. Clinical trials investigating farnesyltransferase inhibitors (FTIs), statins, and bisphosphonates as HGPS treatments are currently underway. FTIs prevent farnesylation and localization of progerin to the cell membrane but do not repair the function of the abnormal progerin protein within the cytoplasm that may result in abnormalities in cell function and DNA repair that, therefore, would not be treated with these drugs. Thus some other novel treatment strategies are required for the more effective treatment. This review summarizes the clinical characteristics of this disease, the underlying mutation in the lamin A (LMNA) gene that results in this phenotype and the recent advances in treatment strategies.

Authors and Affiliations

Ahsas Goyal, Neetu Agrawal, Bhupesh C. Semwal, Yogesh Murti

Keywords

Related Articles

ANTI-DIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF ELAEOCARPUS SERRATUS L. IN STREPTOZOTOCIN-INDUCED DIABETIC RATS

To investigate the anti-diabetic activity of Elaeocarpus serratus fruit in streptozotocin-induced (STZ) diabetic rats. The dose-dependent effects of 30days oral treatment with ethanol extracts of fruit (200 and 400 mg/kg...

EFFECT OF ROOTS OF ORIGANUM MAJORANA IN METHANOLIC AND ETHYL ACETATE EXTRACTS ON CCL4-INDUCED HEPATOTOXICITY IN RAT

To evaluate the hepatoprotective activity of different solvent extracts of Origanum majorana. The root materials were shade dried and were extracted in a soxhlet apparatus successively with ethyl acetate and methanol. Th...

FORMULATION AND IN VITRO EVALUATION OF PIROXICAM EMULGEL

The present work is concerned with the formulation and evaluation of Piroxicam emulgel employing carbopol 934 and xanthan gum as polymers. The emulgel is prepared by combining the gel and emulsion. The gel in formulation...

IN VITRO & IN VIVO EVALUATION OF PRAMIPEXOLE HCL MUCOADHESIVE MICROSPHERES

The study was aimed to design and develop the novel gastro retentive mucoadhesive Pramipexole microspheres using ionotropic gelation technique. Based on the results of Micromeretic properties confirmed that microspheres...

NEUROINFLAMMATION IN ALZHEIMER’S DISEASE AND INVOLVEMENT OF INTERLEUKIN-1: A MECHANISTIC VIEW

Ageing is a universal biological fact and a natural process. It begins from the day we are born, or perhaps even before. Of the world’s 580 million elderly, 77 million (22% of total) live in India. The increasing life ex...

Download PDF file
  • EP ID EP624995
  • DOI -
  • Views 60
  • Downloads 0

How To Cite

Ahsas Goyal, Neetu Agrawal, Bhupesh C. Semwal, Yogesh Murti (2014). HUTCHINSON-GILFORD PROGERIA SYNDROME: A PREMATURELY AGING DISORDER. International Journal of Pharmaceutical Sciences and Drug Research, 6(4), 253-262. https://europub.co.uk/articles/-A-624995